Global Multiplex Assays Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Type;

Protein Multiplex Assays - Planar Protein Assays, Bead-Based Protein Assays, Nucleic Acid Multiplex Assays - Planar Nucleic Acid Assays, Bead-Based Nucleic Acid Assays, and Cell-Based Multiplex Assays.

By Product;

Consumables , Instruments & Software, and Services.

By Technology;

Flow Cytometry , Fluorescence Detection , Luminescence , Multiplex Real-Time PCR, and Other Technologies.

By End User;

Pharmaceutical & Biotechnology Companies , Hospitals & Research Institutes , Reference Laboratories, and Other End Users.

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn139614201 Published Date: March, 2025 Updated Date: May, 2025

Introduction

Global Multiplex Assays Market (USD Million), 2021 - 2031

In the year 2024, the Global Multiplex Assays Market was valued at USD 7,429.22 million. The size of this market is expected to increase to USD 11,712.88 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.7%.

The global multiplex assay market has witnessed significant growth and is expected to continue expanding in the coming years. Multiplex assays offer a technique to simultaneously detect and quantify various analytes, including growth factors, chemokines, cytokines, and proteins. They find broad applications in mutation analysis, linkage analysis, pathogen identification, forensic studies, and gene detection analysis. The industry's growth is driven by factors such as the increasing prevalence of chronic and infectious diseases, the advantages of multiplex assays over traditional methods, their applications in companion diagnostics, and rising awareness about early diagnosis.

Key players in the industry have undertaken various growth initiatives to meet the evolving demands of the healthcare sector. For instance, Thermo Fisher Scientific developed a multiplex real-time PCR diagnostic kit to aid in the rapid diagnosis of SARS-CoV-2 infection. Additionally, multiplex assays are increasingly adopted in drug development processes and clinical trials. They enable the simultaneous determination of infection with multiple pathogens, helping to study disease efficacy and detect antibodies against various diseases.

The advantages of multiplex assays over singleplex and traditional methods are expected to fuel industry growth. These benefits include reduced sample consumption, high operational efficiency, easy operations, and reduced labor costs. The ability to measure various arrays in a single trial leads to quicker results. With advancements like the launch of multiplex assays that provide reliable diagnosis for respiratory infections in a short time frame, the applications of multiplex assays in healthcare are expected to expand, contributing significantly to industry growth. Moreover, the increasing use of multiplex assays in companion diagnostics is expected to accelerate growth, particularly in personalized medicine, where therapies are tailored to individual patients based on the molecular basis of their disease.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Product
    3. Market Snapshot, By Technology
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Global Multiplex Assays Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Disease prevalence
        2. Diagnostic efficiency
        3. Therapeutic development
        4. Companion diagnostics
      2. Restraints
        1. Standardization
        2. Data Interpretation
        3. Sample Compatibility
        4. Regulatory Challenges
      3. Opportunities
        1. Technological Advancements
        2. Expanding Applications
        3. Rising Demand for Personalized Medicine
        4. Emerging Markets
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Multiplex Assays Market, By Type, 2021 - 2031 (USD Million)
      1. Protein Multiplex Assays
        1. Planar Protein Assays
        2. Bead-Based Protein Assays
      2. Nucleic Acid Multiplex Assays
        1. Planar Nucleic Acid Assays
        2. Bead-Based Nucleic Acid Assays
      3. Cell-Based Multiplex Assays
    2. Global Multiplex Assays Market, By Product, 2021 - 2031 (USD Million)
      1. Consumables
      2. Instruments & Software
      3. Services
    3. Global Multiplex Assays Market, By Technology, 2021 - 2031 (USD Million)
      1. Flow Cytometry
      2. Fluorescence Detection
      3. Luminescence
      4. Multiplex Real-Time PCR
      5. Other Technologies
    4. Global Multiplex Assays Market, By End User, 2021 - 2031 (USD Million)
      1. Pharmaceutical & Biotechnology Companies
      2. Hospitals & Research Institutes
      3. Reference Laboratories
      4. Other End Users
    5. Global Multiplex Assays Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia/New Zealand
        5. South Korea
        6. ASEAN
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Luminex Corp.
      2. Bio-Rad Laboratories, Inc.
      3. Abcam plc.
      4. Seegene Inc.
      5. Merck KGaA
      6. Assay Genie
      7. Promega Connections
      8. QIAGEN N.V.
      9. Thermo Fisher Scientific
      10. Perkin Elmer Inc.
      11. Advanced Cell Diagnostics, Inc.
      12. R&D Systems, Inc.
  7. Analyst Views
  8. Future Outlook of the Market